All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

The 'Wolverine stack' peptide craze: what the science says

Cristina with no H

TikTok creator

199.9K viewsWatch on TikTok→

Quick answer

This video instructs viewers on how to calculate injection volumes for a compounded blend of GHK-Cu (50mg), TB-500 (10mg), and BPC-157 (10mg) using free online peptide calculators, with the creator self-reporting a 5mg daily subcutaneous dose diluted in 3mL bacteriostatic water. None of these three peptides have completed peer-reviewed human clinical trials supporting systemic injectable use for cosmetic or regenerative purposes, and BPC-157 currently faces significant FDA compounding restrictions in the United States. Daily self-injection of an unmonitored multi-peptide stack at these concentrations carries unknown safety risks that the video does not address.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @cristina.noh actually say?

She gave a dosing walkthrough, not a medical recommendation. The core claim is straightforward: plug three numbers into a free online peptide calculator (your desired dose, the peptide blend's total concentration, and your bacteriostatic water volume) and it spits out your injection volume. She says she uses a 50-10-10 blend of GHK-Cu, TB-500, and BPC-157, doses at five milligrams total, dilutes in three milliliters of bacteriostatic water, and ends up drawing to the 20-unit mark on an insulin syringe.

She frames it as a how-to for the math, not a prescription. She does mention getting your dose either through "your own research or your consultation with a practitioner," which is a loose but technically real disclaimer. The video is essentially arithmetic instruction for people who already have peptides in hand. That's an important distinction, but it doesn't make the underlying practice risk-free.

Does the science back this up?

The math itself is correct. Whether the peptides inside that syringe do what the hashtag promises is a much harder question. The evidence base for all three compounds is thin in humans, especially at the doses and combinations being discussed.

GHK-Cu has the most published research, primarily in vitro and animal studies showing effects on wound healing, collagen synthesis, and skin remodeling (Pickart & Margolina, 2018, Biomedicines). Human clinical trials are sparse and mostly limited to topical formulations, not injectable systemic doses. BPC-157 has compelling rodent data on gut healing and tendon repair, but as of 2024 there are no completed peer-reviewed human clinical trials registered with the FDA (Sikiric et al., 2018, Current Pharmaceutical Design). TB-500, the synthetic fragment of Thymosin Beta-4, has similarly promising animal data for tissue repair and inflammation modulation, but human evidence is essentially anecdotal or from small uncontrolled studies. Stacking all three in a single compound and injecting it daily is not a protocol validated in any published human trial.

What did they get wrong (or right)?

The calculator method itself is accurate. Dilution math for reconstituted peptides is standard practice in clinical compounding, and the logic she walks through is not wrong. Using three milliliters of bacteriostatic water versus two to reduce injection burn is a reasonable practical note, not a medical claim.

What she gets wrong, or at least glosses over, is significant. First, she never mentions that this stack is not FDA-approved in any form. BPC-157 in particular was placed on the FDA's list of bulk drug substances that cannot be compounded under Section 503A and 503B as of 2023, meaning it is not legally available through licensed U.S. compounding pharmacies for most applications. Second, the phrase "glow peptide" implies cosmetic and aesthetic benefits that have not been demonstrated in controlled human trials for injected GHK-Cu at these doses. Third, daily dosing of a five-milligram multi-peptide stack without any monitoring described is a protocol that has no published safety data to stand behind.

What should you actually know?

If you are considering any of these peptides, the regulatory and safety picture matters more than the dosing math. BPC-157's compounding status in the U.S. is legally complicated right now, and sourcing peptides from unregulated online vendors carries real contamination and dosing accuracy risks. A 2022 analysis published in JAMA found that compounded peptides from grey-market sources frequently contain incorrect concentrations or unlisted ingredients (Gupta et al., 2022, JAMA Internal Medicine).

The "Wolverine stack" branding is marketing, not medicine. Regenerative peptide research is genuinely interesting and worth watching, but the gap between rodent studies and "inject this every day for your glow" is enormous. If you work with a licensed telehealth provider who can monitor labs and adjust dosing, that is a different conversation than following a TikTok calculator tutorial. The math in the video is fine. The implied safety and efficacy are not established.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksBPC-157Provider discussion

Evidence signal

Source-backed review

Regulatory reality

BPC-157 access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For The 'Wolverine stack' peptide craze: what the science says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

BPC-157 is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

Compare providers, services and access requirements in the directory before contacting a suitable care team.

Claim path

Keep researching this bpc-157 video claims cluster

Best for searchers trying to separate BPC-157 research signals from overconfident recovery claims.

Claim verdict

The useful answer behind this video

Claim being checked

This video instructs viewers on how to calculate injection volumes for a compounded blend of GHK-Cu (50mg), TB-500 (10mg), and BPC-157 (10mg) using free online peptide calculators, with the creator self-reporting a 5mg daily subcutaneous dose diluted in 3mL bacteriostatic water.

FormBlends verdict

This video instructs viewers on how to calculate injection volumes for a compounded blend of GHK-Cu (50mg), TB-500 (10mg), and BPC-157 (10mg) using free online peptide calculators, with the creator self-reporting a 5mg daily subcutaneous dose diluted in 3mL bacteriostatic water. None of these three peptides have completed peer-reviewed human clinical trials supporting systemic injectable use for cosmetic or regenerative purposes, and BPC-157 currently faces significant FDA compounding restrictions in the United States. Daily self-injection of an unmonitored multi-peptide stack at these concentrations carries unknown safety risks that the video does not address.

Patient-safe next step

Compare the claim with the BPC-157 guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • This video instructs viewers on how to calculate injection volumes for a compounded blend of GHK-Cu (50mg), TB-500 (10mg), and BPC-157 (10mg) using free online peptide calculators, with the creator self-reporting a 5mg daily subcutaneous dose diluted in 3mL bacteriostatic water. None of these three peptides have completed peer-reviewed human clinical trials supporting systemic injectable use for cosmetic or regenerative purposes, and BPC-157 currently faces significant FDA compounding restrictions in the United States. Daily self-injection of an unmonitored multi-peptide stack at these concentrations carries unknown safety risks that the video does not address.
  • The dilution math in the video is arithmetically correct: desired dose divided by total peptide concentration multiplied by water volume equals injection volume.
  • BPC-157 was added to the FDA's list of prohibited bulk compounding substances in 2023, meaning licensed U.S. compounding pharmacies face significant restrictions on its use.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • BPC-157 decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the BPC-157 guide, cost path, safety notes, and provider review before acting.

Review BPC-157

What You'll Learn

  • The dilution math in the video is arithmetically correct: desired dose divided by total peptide concentration multiplied by water volume equals injection volume.
  • BPC-157 was added to the FDA's list of prohibited bulk compounding substances in 2023, meaning licensed U.S. compounding pharmacies face significant restrictions on its use.
  • A 2022 JAMA Internal Medicine analysis found grey-market compounded peptides frequently contain incorrect concentrations or unlisted additives, making sourcing critically important.
  • GHK-Cu human evidence is largely limited to topical use; Pickart and Margolina (2018, Biomedicines) document skin remodeling effects but primarily in vitro and topical contexts, not systemic injectable protocols.
  • BPC-157 has no completed peer-reviewed human RCTs as of 2024; existing evidence is rodent-based (Sikiric et al., 2018, Current Pharmaceutical Design).
  • The 'Wolverine stack' and 'glow peptide' labels are branding terms with no clinical definition, and no published trial has tested this three-peptide combination in humans.
  • Anyone considering injectable peptide therapy should work with a licensed provider who can assess lab values, monitor for adverse effects, and verify the legal compounding status of each compound.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Cristina with no H · TikTok creator

199.9K views on this video

Guidance on resources for dosing your glow (Wolverine) peptide stack of ghk-cu, bpc-157 and tb500. #glowpeptide #wolverinestack #glowstack #ghkcu #peptide

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Cristina with no H, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.